Please login to the form below

Not currently logged in
Email:
Password:

pipelines

This page shows the latest pipelines news and features for those working in and with pharma, biotech and healthcare.

Poseida gets Novartis backing for myleoma CAR-T challenger

Poseida gets Novartis backing for myleoma CAR-T challenger

San Diego firm joins crowded field. Gene-engineering specialist Poseida Therapeutics is launching its own challenger into the crowded CAR-T pipeline for multiple myeloma, and has just gained backing from ... Novartis. The San Diego-based start-up company

Latest news

More from news
Approximately 14 fully matching, plus 1,659 partially matching documents found.

Latest Intelligence

  • The Orkambi row explained The Orkambi row explained

    effective pipeline treatments for even more of the CF population – but that’s not how NICE works. ... November: Promising data released from phase 3 trials of pipeline cystic fibrosis triple therapy that could benefit more than 90% of people with CF.

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    bullet. That is reflected in the diversification of the pipeline. As of January 2018, more than half of phase 3 Alzheimer’s assets were anti-amyloid therapies. ... In phase 2, the figure fell to less than one-third. Data on the early-stage pipeline is

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    There has been a lot of chatter about developing the tool for therapeutic use, and some specialised pharma companies such as Editas already have candidates in the pipeline. ... He adds: “Our hope is that we can bring better validated drug projects into

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Analysts predict the drug could make up to $2bn in peak sales, making it one of the brightest prospects in Shire’s pipeline.

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    2. The pipeline is booming:Drug approvals are on a steady increase globally. ... 3. The science is increasingly more complex:Many of the highest-potential innovations in the pipeline answer unmet needs in largely elusive disease states.

More from intelligence
Approximately 1 fully matching, plus 135 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 178 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 35 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics